Advertisement
Screener

ZIMMER BIOMET HOLDINGS, INC. (ZBH) Other Comprehensive Income (Loss), before Reclassifications, Net of Tax

1.7 / 5 stars · 36/109 Roast Me

ZIMMER BIOMET HOLDINGS, INC. Other Comprehensive Income (Loss), before Reclassifications, Net of Tax

ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Other Comprehensive Income (Loss), before Reclassifications, Net of Tax of $44.00 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-10-30.

Financial Statements › Income Statement › Unrealized Gains

us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax · last filed 2024-10-30

  • ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2024-09-30 was $11.20M, a 0.00% change year-over-year.
  • ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2024-06-30 was $33.90M, a 64.56% increase year-over-year.
  • ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2024-03-31 was -$1.10M, a 105.19% decline year-over-year.
  • ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2023-12-31 was $18.50M.
  • ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), before reclassifications, net of tax for fiscal 2021 was $60.00M.
  • ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), before reclassifications, net of tax for fiscal 2020 was -$20.30M.
  • ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), before reclassifications, net of tax for fiscal 2019 was -$24.40M.
  • ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), before reclassifications, net of tax for fiscal 2018 was -$96.90M.
Period endOther Comprehensive Income (Loss), before Reclassifications, Net of Tax 3 monthOther Comprehensive Income (Loss), before Reclassifications, Net of Tax 6 monthOther Comprehensive Income (Loss), before Reclassifications, Net of Tax 9 monthOther Comprehensive Income (Loss), before Reclassifications, Net of Tax 12 month
2024-09-30$11.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30
$45.10M
derived: sum of 2 quarters · filed 2024-10-30
$44.00M
10-Q · filed 2024-10-30
$62.50M
derived: sum of 4 quarters · filed 2024-10-30
2024-06-30$33.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
$32.80M
10-Q · filed 2024-08-07
$51.30M
derived: sum of 3 quarters · filed 2024-08-07
$62.50M
derived: sum of 4 quarters · filed 2024-08-07
2024-03-31-$1.10M
10-Q · filed 2024-05-02
$17.40M
derived: sum of 2 quarters · filed 2024-08-07
$28.60M
derived: sum of 3 quarters · filed 2024-08-07
$49.20M
derived: sum of 4 quarters · filed 2024-08-07
2023-12-31$18.50M
derived: 8-K 12 month − 10-Q 9 month · filed 2024-08-07
$29.70M
derived: sum of 2 quarters · filed 2024-08-07
$50.30M
derived: sum of 3 quarters · filed 2024-08-07
$71.50M
8-K · filed 2024-08-07
2023-09-30$11.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
$31.80M
derived: sum of 2 quarters · filed 2023-11-07
$53.00M
10-Q · filed 2023-11-07
2023-06-30$20.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01
$41.80M
10-Q · filed 2023-08-01
2023-03-31$21.20M
10-Q · filed 2023-05-02
2022-09-30-$64.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02
-$68.20M
derived: sum of 2 quarters · filed 2022-11-02
-$53.20M
10-Q · filed 2022-11-02
$15.80M
derived: sum of 4 quarters · filed 2022-11-02
2022-06-30-$3.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02
$11.50M
10-Q · filed 2022-08-02
$80.50M
derived: sum of 3 quarters · filed 2022-08-02
$62.10M
derived: sum of 4 quarters · filed 2022-08-02
2022-03-31$15.00M
10-Q · filed 2022-05-05
$84.00M
derived: sum of 2 quarters · filed 2022-05-05
$65.60M
derived: sum of 3 quarters · filed 2022-05-05
$54.20M
derived: sum of 4 quarters · filed 2022-05-05
2021-12-31$69.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25
$50.60M
derived: sum of 2 quarters · filed 2022-02-25
$39.20M
derived: sum of 3 quarters · filed 2022-02-25
$60.00M
10-K · filed 2022-02-25
2021-09-30-$18.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
-$29.80M
derived: sum of 2 quarters · filed 2021-11-04
-$9.00M
10-Q · filed 2021-11-04
-$15.30M
derived: sum of 4 quarters · filed 2021-11-04
2021-06-30-$11.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03
$9.40M
10-Q · filed 2021-08-03
$3.10M
derived: sum of 3 quarters · filed 2021-08-03
-$11.80M
derived: sum of 4 quarters · filed 2021-08-03
2021-03-31$20.80M
10-Q · filed 2021-05-04
$14.50M
derived: sum of 2 quarters · filed 2021-05-04
-$400.00K
derived: sum of 3 quarters · filed 2021-05-04
-$100.00K
derived: sum of 4 quarters · filed 2021-05-04
2020-12-31-$6.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22
-$21.20M
derived: sum of 2 quarters · filed 2021-02-22
-$20.90M
derived: sum of 3 quarters · filed 2021-02-22
-$20.30M
10-K · filed 2021-02-22
2020-09-30-$14.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
-$14.60M
derived: sum of 2 quarters · filed 2020-11-06
-$14.00M
10-Q · filed 2020-11-06
-$19.30M
derived: sum of 4 quarters · filed 2020-11-06
2020-06-30$300.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
$900.00K
10-Q · filed 2020-08-05
-$4.40M
derived: sum of 3 quarters · filed 2020-08-05
-$49.10M
derived: sum of 4 quarters · filed 2020-08-05
2020-03-31$600.00K
10-Q · filed 2020-05-11
-$4.70M
derived: sum of 2 quarters · filed 2020-05-11
-$49.40M
derived: sum of 3 quarters · filed 2020-05-11
-$33.90M
derived: sum of 4 quarters · filed 2020-05-11
2019-12-31-$5.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21
-$50.00M
derived: sum of 2 quarters · filed 2020-02-21
-$34.50M
derived: sum of 3 quarters · filed 2020-02-21
-$24.40M
10-K · filed 2020-02-21
2019-09-30-$44.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05
-$29.20M
derived: sum of 2 quarters · filed 2019-11-05
-$19.10M
10-Q · filed 2019-11-05
-$41.90M
derived: sum of 4 quarters · filed 2019-11-05
2019-06-30$15.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05
$25.60M
10-Q · filed 2019-08-05
$2.80M
derived: sum of 3 quarters · filed 2019-08-05
-$9.70M
derived: sum of 4 quarters · filed 2019-08-05
2019-03-31$10.10M
10-Q · filed 2019-05-06
-$12.70M
derived: sum of 2 quarters · filed 2019-05-06
-$25.20M
derived: sum of 3 quarters · filed 2019-05-06
-$149.10M
derived: sum of 4 quarters · filed 2019-05-06
2018-12-31-$22.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
-$35.30M
derived: sum of 2 quarters · filed 2019-02-26
-$159.20M
derived: sum of 3 quarters · filed 2019-02-26
-$96.90M
10-K · filed 2019-02-26
2018-09-30-$12.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01
-$136.40M
derived: sum of 2 quarters · filed 2018-11-01
-$74.10M
10-Q · filed 2018-11-01
2018-06-30-$123.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06
-$61.60M
10-Q · filed 2018-08-06
2018-03-31$62.30M
10-Q · filed 2018-05-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
STERIS plc (STE)Ireland$20.343B25.49
ALIGN TECHNOLOGY INC (ALGN)United States$10.346B29.06
MSA Safety Inc (MSA)United States$7.023B21.47
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)$1.954B-65.76
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Enovis CORP (ENOV)United States$1.053B-1.18
Anteris Technologies Global Corp. (AVR)United States$0.746B
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81
Inogen Inc (INGN)United States$0.139B-7.00
Conexeu Sciences Inc. (CNXU)United States$0.111B